Yasumura S, Ellis K J, Cohn S H
J Lab Clin Med. 1976 Nov;88(5):834-40.
Administration of 5 mg. of hydrocortisone acetate to rats every other day for 2 weeks resulted in growth retardation and weight loss as indicated by body weights of experimental animals, which averaged 33 per cent lower than those of the controls, and a significant decrease in the length of the tibiae and femurs (p less than 0.01 for treated vs controls). However, despite the smaller size of the treated animals, the values for total body calcium (TBCa) and the calcium in the tibia and femur did not differ significantly from control values. Thus, there was more calcium per unit length of bone, resulting in an increase in the skeletal density of treated rats. This finding was confirmed by x-ray examination of these bones. The net intestinal absorption of calcium (rate of initial entry) calculated from plasma levels following an oral and intravenous dose of 47Ca and 85Sr, respectively, was not significantly different in hydrocortisone-treated rats compared to controls. This would indicate that the rate of intestinal absorption of calcium is unimpaired despite the administration of massive doses and corticosteroids. When the animals were placed on a calcium-deficient diet, both TBCa and tibia and femur calcium levels were decreased. Subsequent administration and hydrocortisone did not alter the calcium values. The results of this study are compatible with the hypothesis that hydrocortisone promotes weight loss, retards growth, but inhibits the rate of bone resorption.
每隔一天给大鼠注射5毫克醋酸氢化可的松,持续2周,结果显示实验动物体重出现生长迟缓和体重减轻,其平均体重比对照组低33%,胫骨和股骨长度显著缩短(治疗组与对照组相比,p<0.01)。然而,尽管治疗组动物体型较小,但其全身钙总量(TBCa)以及胫骨和股骨中的钙含量与对照组相比并无显著差异。因此,每单位骨长度中的钙含量增加,导致治疗组大鼠的骨骼密度升高。对这些骨骼进行X线检查证实了这一发现。分别通过口服和静脉注射47Ca和85Sr后根据血浆水平计算得出的钙的净肠道吸收(初始进入速率),在氢化可的松治疗的大鼠与对照组之间并无显著差异。这表明尽管给予了大剂量皮质类固醇,但钙的肠道吸收速率并未受损。当动物被置于缺钙饮食中时,TBCa以及胫骨和股骨的钙水平均降低。随后给予氢化可的松并未改变钙值。本研究结果与以下假设相符:氢化可的松促进体重减轻、生长迟缓,但抑制骨吸收速率。